University of Hull
Article summarizes findings relevant to heart failure trials
Published in Law and Health Weekly, February 26th, 2005
According to the report from England, "[Our] article summarizes key presentations relevant to the pathophysiology, prevention or treatment of heart failure, from the Heart Failure Society of America annual meeting held in Toronto, Canada."
K. Lalukota and colleagues of the University of Hull reported, "Data from the EnoxiMone in intravenous inOTropE-dependent subjects (EMOTE) study suggest that the oral PDE-3 inhibitor enoximone may be effective for weaning severe heart failure patients from intravenous...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Biomedical Primate Research Center, Rijswijk
Secondary HIV infections after single exposure in primates investigated - Business Update
Boost in costs for diet drug litigation drags Wyeth to fourth-quarter loss - Coloplast
Discrete catheter SpeediCath Compact for women wins Danish 2004 Product Award - Drug Importation
Some pharmacists reluctant to go along with Oklahoma Governor's idea - Healthcare Coverage
Problems possible with switch in prescription drug benefits in Arizona - HealtheTech, Inc.
Medical device developer resolves legal dispute with Microlife Corporation - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
